ANTIBODY-DEPENDENT ENHANCEMENT

ANTIBODY-DEPENDENT ENHANCEMENT was reported 1 times

ANTIBODY-DEPENDENT ENHANCEMENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] 1 0.0006